Just W, Geerkens C, Held K R, Vogel W
Abteilung für Klinische Genetik der Universität, Ulm, Federal Republic of Germany.
Hum Genet. 1992 May;89(2):240-2. doi: 10.1007/BF00217131.
A series of fibroblasts from patients with numerical or structural aberrations of the X chromosome were scored for the amount of mRNA of ribosomal protein S4 (RPS4X). Haplo-insufficiency of this gene has been reported previously to be a possible cause of Turner syndrome. Our results show that the transcription rate of RPS4X correlates with the number of gene copies. This confirms earlier findings indicating that this gene escapes X inactivation. In addition, we demonstrate that this applies to structurally aberrant X chromosomes. Our results show that RPS4X does not give rise to a type of haplo-insufficiency in these cases, because it escapes inactivation, even on structurally aberrant X chromosomes from patients with Turner syndrome. We therefore assume that RPS4X is not the most prominent candidate gene for Turner syndrome.
对一系列X染色体存在数目或结构异常的患者的成纤维细胞进行核糖体蛋白S4(RPS4X)的mRNA含量测定。此前有报道称该基因的单倍剂量不足可能是特纳综合征的一个病因。我们的结果表明,RPS4X的转录率与基因拷贝数相关。这证实了早期的研究结果,即该基因逃避X染色体失活。此外,我们证明这也适用于结构异常的X染色体。我们的结果表明,在这些情况下RPS4X不会导致单倍剂量不足,因为它逃避失活,即使是来自特纳综合征患者的结构异常的X染色体。因此,我们认为RPS4X不是特纳综合征最主要的候选基因。